Last $24.35 USD
Change Today -0.46 / -1.85%
Volume 541.2K
As of 1:09 PM 09/22/14 All times are local (Market data is delayed by at least 15 minutes).

Insiders at anacor pharmaceuticals inc (ANAC)

Name (Connections)Board RelationshipsTitleType of Board MemberAge
Paul Berns 47 RelationshipsChairman, Chief Executive Officer, President, Chairman of Compensation Committee, Chairman of Transaction Committee and Member of Audit CommitteeChief Executive Officer47
Lucy Shapiro Ph.D.45 RelationshipsCo-Founder, Co-Chair of Scientific Advisory Board, Director and Member of Nominating & Corporate Governance CommitteeTop Key Executive73

Other Board Members on Board*

Name (Connections)Board RelationshipsType of Board MemberPrimary CompanyAge
William Rieflin 30 RelationshipsMember of the Board of DirectorsXenoport, Inc.54
Mark Leschly 146 RelationshipsMember of the Board of DirectorsRho Capital Partners, Inc.45
Martin Rosenberg Ph.D. 40 RelationshipsMember of Advisory BoardVantagePoint Capital Partners68
George Poste Ph.D. 115 RelationshipsMember of Advisory BoardHealth Technology Networks70
Anders Hove M.D. 156 RelationshipsMember of the Board of DirectorsVenrock48
Jonathan Wilkin M.D., F.A.C.P., F.A.A.D 75 RelationshipsMember of Advisory BoardAnacor Pharmaceuticals, Inc.--
Sidney Hecht Ph.D. 17 RelationshipsMember of Advisory BoardAnacor Pharmaceuticals, Inc.70
Lowell Goldsmith M.D., MPH 13 RelationshipsMember of Advisory BoardAnacor Pharmaceuticals, Inc.--
James Leyden M.D. 46 RelationshipsMember of Advisory BoardAnacor Pharmaceuticals, Inc.73
Arnold Smith Ph.D., M.D. 26 RelationshipsMember of Advisory BoardAnacor Pharmaceuticals, Inc.--
Keith Leonard Jr., M.S., M.B.A. 31 RelationshipsMember of the Board of DirectorsKythera Biopharmaceuticals, Inc.52
Wendell Wierenga Ph.D. 125 RelationshipsMember of the Board of DirectorsAgilent Technologies Inc.66
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ANAC:US $24.35 USD -0.46

ANAC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ANAC.
View Industry Companies
 

Industry Analysis

ANAC

Industry Average

Valuation ANAC Industry Range
Price/Earnings 15.4x
Price/Sales 54.2x
Price/Book 12.3x
Price/Cash Flow 15.3x
TEV/Sales 46.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANACOR PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.